ATE421575T1 - Verfahren zur kultivierung neuraler stammzellen unter verwendung des hepatozytenwachstumsfaktors - Google Patents
Verfahren zur kultivierung neuraler stammzellen unter verwendung des hepatozytenwachstumsfaktorsInfo
- Publication number
- ATE421575T1 ATE421575T1 AT03812367T AT03812367T ATE421575T1 AT E421575 T1 ATE421575 T1 AT E421575T1 AT 03812367 T AT03812367 T AT 03812367T AT 03812367 T AT03812367 T AT 03812367T AT E421575 T1 ATE421575 T1 AT E421575T1
- Authority
- AT
- Austria
- Prior art keywords
- stem cells
- growth factor
- neural stem
- hepatocyte growth
- cultivation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/12—Hepatocyte growth factor [HGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Developmental Biology & Embryology (AREA)
- Psychology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43043102P | 2002-12-02 | 2002-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE421575T1 true ATE421575T1 (de) | 2009-02-15 |
Family
ID=32469472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03812367T ATE421575T1 (de) | 2002-12-02 | 2003-12-02 | Verfahren zur kultivierung neuraler stammzellen unter verwendung des hepatozytenwachstumsfaktors |
Country Status (9)
Country | Link |
---|---|
US (1) | US20060134078A1 (de) |
EP (1) | EP1570052B1 (de) |
JP (1) | JP2006511214A (de) |
CN (1) | CN1745168A (de) |
AT (1) | ATE421575T1 (de) |
AU (1) | AU2003302707B2 (de) |
CA (1) | CA2507395A1 (de) |
DE (1) | DE60326003D1 (de) |
WO (1) | WO2004050865A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4126060B2 (ja) * | 2003-10-29 | 2008-07-30 | エフシービー ファーミセル カンパニー,リミテッド | 間葉系幹細胞の神経細胞への分化法と神経変性疾患用の神経細胞含有薬剤成分 |
US8785187B2 (en) | 2004-06-09 | 2014-07-22 | The University Court Of The University Of Edinburgh | Neural stem cells |
JP4868199B2 (ja) * | 2004-09-10 | 2012-02-01 | 学校法人鈴鹿医療科学大学 | サルビアノール酸bを有効成分とする神経幹細胞増殖剤 |
EP1937236A2 (de) * | 2005-09-07 | 2008-07-02 | Braincells, Inc. | Modulation der neurogenese durch hdac-hemmung |
AU2008269029A1 (en) * | 2007-06-27 | 2008-12-31 | President And Fellows Of Harvard College | Neural stem cells |
EP3187581A1 (de) | 2008-12-23 | 2017-07-05 | BOCO Silicon Valley, Inc. | Zielpopulationen von oligodendrozyten-vorläuferzellen und verfahren zur herstellung und verwendung davon |
KR101446711B1 (ko) * | 2011-05-23 | 2014-10-06 | 아주대학교산학협력단 | 간세포 성장인자 유전자 및 염기성 나선-고리-나선 계열의 신경형성 전사인자 유전자가 도입된 성체 줄기세포주 및 그의 용도 |
CN102399747B (zh) * | 2011-11-24 | 2014-04-16 | 吉林省拓华生物科技有限公司 | 神经干细胞的传代分离方法 |
EP3438249A4 (de) * | 2016-03-31 | 2019-10-30 | Ajinomoto Co., Inc. | Medium für neurale stammzellen zur verbesserung der neuralen differenzierungsfähigkeit |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5753505A (en) * | 1995-07-06 | 1998-05-19 | Emory University | Neuronal progenitor cells and uses thereof |
US5968829A (en) * | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
US6184035B1 (en) * | 1998-11-18 | 2001-02-06 | California Institute Of Technology | Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells |
JP2002536423A (ja) * | 1999-02-11 | 2002-10-29 | ザ スキーペンズ アイ リサーチ インスティテュート インコーポレイテッド | 未成熟及び成熟ジストロフィーレシピエントの神経組織内に移植された神経前駆細胞の統合 |
KR100449141B1 (ko) * | 2001-04-19 | 2004-09-21 | (주)라이프코드 | 간엽 간세포를 신경세포로 분화시키는 방법 |
-
2003
- 2003-12-02 AU AU2003302707A patent/AU2003302707B2/en not_active Ceased
- 2003-12-02 EP EP03812367A patent/EP1570052B1/de not_active Expired - Lifetime
- 2003-12-02 CN CNA2003801094557A patent/CN1745168A/zh active Pending
- 2003-12-02 WO PCT/JP2003/015401 patent/WO2004050865A1/en active Application Filing
- 2003-12-02 AT AT03812367T patent/ATE421575T1/de not_active IP Right Cessation
- 2003-12-02 CA CA002507395A patent/CA2507395A1/en not_active Abandoned
- 2003-12-02 US US10/536,563 patent/US20060134078A1/en not_active Abandoned
- 2003-12-02 JP JP2004556885A patent/JP2006511214A/ja active Pending
- 2003-12-02 DE DE60326003T patent/DE60326003D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1570052B1 (de) | 2009-01-21 |
CN1745168A (zh) | 2006-03-08 |
CA2507395A1 (en) | 2004-06-17 |
US20060134078A1 (en) | 2006-06-22 |
JP2006511214A (ja) | 2006-04-06 |
EP1570052A1 (de) | 2005-09-07 |
WO2004050865A1 (en) | 2004-06-17 |
DE60326003D1 (de) | 2009-03-12 |
AU2003302707A1 (en) | 2004-06-23 |
AU2003302707B2 (en) | 2008-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE406435T1 (de) | Methoden zur züchtung von tierzellen | |
DK0960944T3 (da) | Forbedret produktion af taxol og taxaner fra cellekulturer af taxus-arter | |
ATE550430T1 (de) | Aus bakterien der gattung corynebacterium stammende promoternukleinsäure , den promoter umfassende expressionskassette , den vektor umfassende wirtszelle sowie verfahren zur expression eines gens unter verwendung der zelle . | |
DE60017875D1 (de) | Verwendung von collagenase in der zubereitung von neuralen stammzellkulturen | |
ATE513901T1 (de) | Neurale vorläuferzellen | |
DE50108487D1 (de) | Bioreaktor für die kultivierung von mikroorganismen sowie verfahren zur herstellung desselben | |
ATE443757T1 (de) | L-aminosäure produzierender mikroorganismus und verfahren zur l-aminosäureproduktion | |
DE60313188D1 (de) | Verfahren und medien zur kontrolle der sialysierung von proteinen, die von säugetierzellen produziert werden | |
ATE421575T1 (de) | Verfahren zur kultivierung neuraler stammzellen unter verwendung des hepatozytenwachstumsfaktors | |
ATE353953T1 (de) | Wirtszelle, die reduzierte mengen einer metalloprotease exprimiert und methoden zur verwendung dieser wirtszelle zur proteinproduktion | |
ATE265802T1 (de) | Verfahren zum erzeugen von metaboliten aus pflanzen in erdloser kultur | |
WO2003010304A3 (de) | Verfahren zur herstellung isolierter zellkulturen, kulturmedium zur kultivierung von zellkulturen und zellkultur | |
TW200506058A (en) | Method for culturing organic blue-green algae | |
DE502005006003D1 (de) | Verfahren zur herstellung einer epithelzellen enthaltenden zellzusammensetzung | |
DE60105435D1 (de) | Verfahren zur herstellung von beta-karotin | |
ATE391787T1 (de) | Verfahren zur herstellung von ubiquinon-10 | |
DE69919989D1 (de) | Verfahren zur herstellung transgener pflanzen unter verwendung von apikalspriessenspitzen | |
ATE378397T1 (de) | Verfahren zum kultivieren von mikroorganismen unter reduzierenden bedingungen mittels einer gasströmung | |
ATE214736T1 (de) | Verfahren zur fermentativen herstellung von l- aminosäuren unter verwendung coryneformer bakterien | |
NO964368D0 (no) | Fremgangsmåte for regulering av metallfosfatutfelling ved höy celletetthetsfermentering | |
ATE310095T1 (de) | Verfahren zur modulierung des niveaus von organischen schwefelverbindungen in pflanzen | |
DE502006005197D1 (de) | Mikroorganismen burkholderia rhizoxina, neue endosymbionten aus rhizopus sp. und verfahren zur herstellung von rhizoxin und / oder rhizoxin-derivaten unter verwendung dieser mikroorganismen | |
ATE417919T1 (de) | Mikrobiologisches verfahren zur herstellung von amiden | |
DE69911284D1 (de) | Pflanzenzuchtmittel aus Holzfasern und Verfahren zur Herstellung eines solchen Zuchtmittels | |
ATE486124T1 (de) | Keratinozyten-kulturverfahren und verwendung davon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |